teva generic androgel
PHARMACY

Teva launches generic AndroGel

BY Sandra Levy

Teva is introducing its generic AndroGel (testosterone gel 1.62%).

Testosterone gel 1.62%  is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: congenital or acquired primary hypogonadism and congenital or acquired hypogonadotropic hypogonadism. It is a Schedule III controlled substance.

Testosterone gel 1.62% had a market value of more than $911 million, according to February 2019 IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer